Invention Grant
- Patent Title: Pyrrolopyridine derivatives and their use as CRTH2 antagonists
- Patent Title (中): 吡咯并吡啶衍生物及其用作CRTH2拮抗剂
-
Application No.: US13910769Application Date: 2013-06-05
-
Publication No.: US08791256B2Publication Date: 2014-07-29
- Inventor: Kamlesh Jagdis Bala , Catherine Leblanc , David Andrew Sandham , Katharine Louise Turner , Simon James Watson , Lyndon Nigel Brown , Brian Cox
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Michael G. Smith
- Priority: GB0413619.8 20040617; GB0507693.0 20050415
- Main IPC: C07D471/04
- IPC: C07D471/04
Abstract:
There are provided according to the invention compounds of formula (I) in free or salt form, wherein R1, R2, R3, R4, R5, R6, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.
Public/Granted literature
- US20130267518A1 PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS CRTH2 ANTAGONISTS Public/Granted day:2013-10-10
Information query
